Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,084 across all filing types
Latest filing 2023-08-22 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
关于增加经营范围并修订《公司章程》的公告
Board/Management Information Classification · 95% confidence The document is an official announcement from a company regarding the increase in its business scope and the revision of its Articles of Association (公司章程). It details the changes approved by the board and to be submitted to the shareholders' meeting. The content is about corporate governance changes and operational scope adjustments, not a financial report, earnings release, or regulatory certification. It is not a full report but an announcement of corporate changes. This fits the category of Board/Management Information (MANG), which covers announcements of changes in company governance or management-related decisions.
2023-08-22 Chinese
独立董事关于控股股东及其他关联方占用公司资金、公司对外担保情况的专项说明和独立意见
Audit Report / Information Classification · 95% confidence The document is a special statement and independent opinion from independent directors regarding the company's related party fund occupation and external guarantees for the first half of 2023. It references regulatory rules and laws but does not contain financial statements or detailed financial data. It is a standalone audit-related opinion on specific matters, not a full annual or interim report. The document length is short and focused on audit-related independent opinions, fitting the category of Audit Report / Information (AR). H1 2023
2023-08-22 Chinese
半年报监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a meeting resolution announcement from the Supervisory Board (监事会) of the company 西藏易明西雅医药科技股份有限公司. It discusses the approval of the 2023 semi-annual report and its summary, confirming the report's compliance and accuracy, but does not contain the report itself. It also mentions the approval of amendments to the company's business scope and articles of association, which will be submitted to a shareholders' meeting. The document is short (1123 characters) and primarily serves as an announcement of meeting resolutions rather than the full semi-annual report. According to the 'Menu vs Meal' rule, this is not the interim report itself but an announcement related to it. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement and does not fit other specific categories.
2023-08-22 Chinese
西藏易明西雅医药科技股份有限公司章程（2023年8月修订）
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of 西藏易明西雅医药科技股份有限公司, dated August 2023. It contains detailed chapters on company organization, shareholder rights, board of directors, management, financial accounting, profit distribution, auditing, and other governance-related matters. The content is focused on the internal rules, structure, and governance practices of the company rather than financial results, meeting announcements, or voting results. It is a comprehensive governance document that outlines the company's bylaws and operational framework. Therefore, this document fits the category of Governance Information (CGR).
2023-08-22 Chinese
2023年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "西藏易明西雅医药科技股份有限公司2023 年半年度报告全文" which translates to "Tibet Aim Pharmaceutical Technology Co., Ltd. 2023 Semi-Annual Report Full Text." It explicitly states it is a "半年度报告" (half-year report) covering the period from January 1, 2023 to June 30, 2023. The content includes detailed financial data, management discussion and analysis, business overview, financial indicators, and other comprehensive information typical of an interim or quarterly report. The document length is about 15,000 characters, indicating it is a full report rather than a brief announcement. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2023
2023-08-22 Chinese
半年度非经营性资金占用及其他关联资金往来情况汇总表
Interim / Quarterly Report Classification · 85% confidence The document is a summary table detailing the non-operating fund occupation and other related party fund transactions for the half-year period of 2023. It includes financial figures such as amounts occupied, interest, repayments, and balances, along with explanations of the nature of these transactions. The document is relatively short (1544 characters) and appears to be a specific financial disclosure related to related-party transactions rather than a comprehensive financial report. It does not contain full financial statements or detailed management discussion and analysis. It is not an announcement of a report but a specific financial summary. Given the nature of the content, it fits best under the category of Interim / Quarterly Report (IR) because it provides substantive financial data for a half-year period, which is shorter than a full fiscal year, and includes detailed financial figures and analysis of related party transactions. H1 2023
2023-08-22 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.